Efficacy of pentoxifylline in the treatment of pruritic papular eruption of HIV-infected persons
Authors:
- Francisco FloresFFFrancisco Flores
- George BurkeGBGeorge Burke
Open Access
- 1 June 1998
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 38 (6) , 955-959
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Correlation of skin disorders with CD4 lymphocyte counts in patients with HIV/AIDSJournal of the American Academy of Dermatology, 1997
- Prurigo nodularis and photosensitivity in AIDS: Treatment with thalidomideJournal of the American Academy of Dermatology, 1995
- UVB phototherapy of the pruritic papular eruption of the acquired immunodeficiency syndromeJournal of the American Academy of Dermatology, 1992
- Thalidomide in Human Immunodeficiency Virus (HIV) PatientsDrug Safety, 1992
- Pruritic papular eruption of the acquired immunodeficiency syndrome: A clinicopathologic studyJournal of the American Academy of Dermatology, 1991
- Pentoxifylline and wellbeing in patients with cancerThe Lancet, 1990
- Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected PersonsNew England Journal of Medicine, 1989
- Induction of Expression of Human Immunodeficiency Virus in a Chronically Infected Promonocytic Cell Line by Ultraviolet IrradiationAIDS Research and Human Retroviruses, 1989
- Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofyllineBiochemical and Biophysical Research Communications, 1988
- Disseminated Kaposi's sarcoma syndrome in young homosexual menJournal of the American Academy of Dermatology, 1981